Form 8-K - Current report:
SEC Accession No. 0001144204-14-057351
Filing Date
2014-09-23
Accepted
2014-09-23 16:06:52
Documents
3
Period of Report
2014-09-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v389839_8k.htm 8-K 19619
2 EXHIBIT 99.1 v389839_ex99-1.htm EX-99.1 12263
3 GRAPHIC image_001.jpg GRAPHIC 63897
  Complete submission text file 0001144204-14-057351.txt   121407
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20713 | Film No.: 141116152
SIC: 2836 Biological Products, (No Diagnostic Substances)